Aclaris Therapeutics (ACRS) Shares Outstanding (2014 - 2026)

Aclaris Therapeutics (ACRS) Shares Outstanding (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6,012.74 Bn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 47.82 Bn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.44 Bn
4 NuCana 279.75 Bn 279.75 Bn - 11.23 Bn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 400.00 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 62.19 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Aclaris Therapeutics 705.88 Mn 705.88 Mn 1.60 Mn 128.81 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 128.81 Mn
Dec 31, 2025 122.56 Mn
Sep 30, 2025 122.62 Mn
Jun 30, 2025 122.58 Mn
Mar 31, 2025 122.39 Mn
Dec 31, 2024 77.30 Mn
Sep 30, 2024 71.38 Mn
Jun 30, 2024 71.29 Mn
Mar 31, 2024 71.07 Mn
Dec 31, 2023 69.81 Mn
Sep 30, 2023 70.81 Mn
Jun 30, 2023 70.63 Mn
Mar 31, 2023 66.87 Mn
Dec 31, 2022 65.21 Mn
Sep 30, 2022 66.68 Mn
Jun 30, 2022 65.99 Mn
Mar 31, 2022 61.43 Mn
Dec 31, 2021 56.73 Mn
Sep 30, 2021 61.22 Mn
Jun 30, 2021 53.97 Mn